Clinical Trials
NRx Pharmaceuticals Announces Positive Results for ZYESAMI and Submits...
NRx Pharmaceuticals , a clinical stage pharmaceutical company, announced it has filed an application with U.S. FDA requesting Emergency Use Authorization (EUA) for ZYESAMIâ„¢ (Aviptadil-acetate),...
Clinical Trials
Moderna Reports Positive COVID-19 Vaccine Results in Adolescents
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents...
Clinical Trials
Bharat Biotechs Covaxin approved for phase 2/3 trials on...
The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two to...
Clinical Trials
INOVIO Announces Positive Data from Phase 2 Segment of...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,...
Clinical Trials
Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira...
LabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc.,...
Clinical Trials
CytoDyn and AEIH to begin trials of leronlimab in...
This development is part of CytoDyn’s agreement to collaborate with AEIH to carry out the trials in up to 45 clinical sites in the country.
These...
Clinical Trials
Eiger to add Peginterferon Lambda to Covid-19 trial in...
Eiger BioPharmaceuticals has said that its investigational agent, Peginterferon Lambda, will be added to the Phase III TOGETHER platform study of Covid-19 outpatients in Brazil.
A...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.